-
China's Walvax says has most participants for large mRNA COVID vaccine trial
FirstWordPharma
January 28, 2022
An official at Walvax Biotechnology said the Chinese company has recruited most of the 28,000 participants needed for a large clinical trial of its mRNA COVID-19 vaccine candidate, as reported in Yahoo!News.
-
Delta variant, waning immunity reduced Pfizer vaccine's effectiveness against household transmission
WorldPharmaNews
January 28, 2022
A new study by Yale School of Public Health (YSPH) researchers suggests that the Pfizer-BioNTech vaccine was more than 91% effective at reducing transmission of coronavirus in Israeli households before the emergence of the delta variant.
-
Ocugen to buy Liminal’s vaccine manufacturing facility in Canada
pharmaceutical-business-review
January 28, 2022
US-based Ocugen has signed a letter of intent (LOI) to acquire Liminal Biosciences’ manufacturing site located in Belleville...
-
Recipharm Secures Vaccine Manufacturing Deal
contractpharma
January 28, 2022
Inks deal with top 10 big pharma and will provide manufacturing support from facility in Kaysersberg, France.
-
Construction Works Launch at New Fill Finish Facility in Morocco
contractpharma
January 28, 2022
SENSYO Pharmatech aims to be the largest fill and finish platform in Africa.
-
Hospital Defends Decision to Deny Heart Transplant to Unvaccinated Man
drugs.com
January 27, 2022
In response to claims that a man was denied a heart transplant because he refused to get vaccinated...
-
Biden Administration Withdraws Vaccine Mandate for Large Employers
drugs.com
January 26, 2022
The Biden administration on Tuesday withdrew an emergency COVID-19 vaccine-or-test mandate...
-
Avanti & Croda-Denmark: Advancing Vaccine Adjuvant Research
CPhIonline
January 24, 2022
In 2020, researchers at Verndari, Inc. investigated a novel microarray skin patch vaccine incorporating subunit glycoprotein antigens and liposomal adjuvants into a trehalose co-formulation.
-
Japan approves Pfizer-BioNTech’s Covid-19 vaccine for children
Pharmaceutical-Technology
January 24, 2022
The vaccine doses that will be administered for children will use one-third of a dose given for adults.
-
Three doses of mRNA COVID vaccines very effective against Omicron and Delta: Study
ExpressPharma
January 24, 2022
The study, from the US Centers for Disease Control and Prevention (CDC), found that boosters of mRNA COVID vaccines are 82 per cent effective in protecting against Omicron variant-associated ED visits.